Dormant Company Accounts - RECTAL BLEEDING CLINIC LIMITED

Dormant Company Accounts - RECTAL BLEEDING CLINIC LIMITED


Companies House true 2022-06-01 2023-05-31 false 07256870 uk-bus:Director1 2022-06-01 2023-05-31 07256870 uk-bus:Director2 2022-06-01 2023-05-31 07256870 2022-06-01 2023-05-31 07256870 2023-05-31 07256870 uk-bus:EntityHasNeverTraded 2022-06-01 2023-05-31 07256870 uk-bus:FRS102 2022-06-01 2023-05-31 07256870 uk-bus:FullAccounts 2022-06-01 2023-05-31 07256870 uk-bus:AuditExempt-NoAccountantsReport 2022-06-01 2023-05-31 07256870 2022-05-31 07256870 uk-bus:OrdinaryShareClass1 2022-06-01 2023-05-31 07256870 uk-bus:OrdinaryShareClass2 2022-06-01 2023-05-31 07256870 uk-bus:OrdinaryShareClass3 2022-06-01 2023-05-31 07256870 uk-bus:PreferenceShareClass1 2022-06-01 2023-05-31 07256870 uk-bus:PreferenceShareClass2 2022-06-01 2023-05-31 07256870 uk-bus:PreferenceShareClass3 2022-06-01 2023-05-31 07256870 uk-core:ShareCapitalPreferenceShares 2023-05-31 07256870 uk-core:ShareCapitalPreferenceShares 2022-05-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 07256870

RECTAL BLEEDING CLINIC LIMITED

Dormant Accounts

31 May 2023

RECTAL BLEEDING CLINIC LIMITED Registered Number 07256870

Balance Sheet as at 31 May 2023

2023 2022
£ £
Called up share capital not paid
1
1
Current assets
Cash at bank and in hand
1
1
Net assets
2
2
Issued share capital
1 Ordinary Share of £ 2 each 2 2
Total Shareholder funds
2
2

STATEMENTS

  1. For the year ending 31 May 2023 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 16 July 2023

And signed on their behalf by:
Oluwaseun Oluwajobi, Director